Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alliance for Biosecurity elects biotech CEOs co-chairs

This article was originally published in Scrip

Executive Summary

The Alliance for Biosecurity, a collaboration among pharmaceutical and biotech companies that are working in the public interest to improve prevention and treatment of severe infectious diseases, has appointed two co-chairs from the biotech sector. Anders Hedegaard, president and CEO of Bavarian Nordic, and Dr Elizabeth Posilico, president and CEO of Elusys Therapeutics, will represent the Alliance before the US government and other agencies to advance the development of new medical countermeasures to be used against chemical, biological, radiological and nuclear threats. Each will serve a two year term which commenced on 1 June 2013.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC021994

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel